Related Experiment Videos
[Epithelioid bilateral ovarian leiomyosarcoma: a study].
Abdelmajid Khabir1, Tahia Boudawara, Lobna Ayadi
1Laboratoire d'anatomie et de cytologie pathologiques, CHU Habib Bourguiba, Sfax, Tunisia. akabdelmajid@yahoo.com
Annales De Pathologie
|May 14, 2003
Summary
Primary ovarian leiomyosarcoma is a rare cancer typically affecting postmenopausal women. This case highlights aggressive recurrence despite surgery and chemotherapy, emphasizing the need for further research into ovarian leiomyosarcoma prognosis.
Area of Science:
- Gynecologic Oncology
- Pathology
- Surgical Oncology
Background:
- Primary ovarian leiomyosarcoma is an exceptionally rare malignancy.
- It predominantly affects postmenopausal women and is often unilateral and large (>10 cm).
- The histogenesis and optimal treatment strategies remain incompletely understood.
Observation:
- A 54-year-old nulliparous, postmenopausal woman presented with abdominal distention due to a large pelvi-abdominal mass.
- Surgical management included tumor excision with bilateral salpingo-oophorectomy and hysterectomy.
- Pathological examination with immunohistochemistry confirmed bilateral ovarian epithelioid leiomyosarcoma.
Findings:
- Despite radical surgery and adjuvant chemotherapy, the patient developed peritoneal recurrence and hepatic metastasis within 3 months.
- This case underscores the aggressive nature and potential for rapid progression of ovarian leiomyosarcoma.
- Histopathological features and immunohistochemical profile were crucial for diagnosis.
Implications:
- Further investigation into the molecular mechanisms driving ovarian leiomyosarcoma is warranted.
- The findings suggest that current adjuvant therapies may have limited efficacy in preventing early recurrence.
- Enhanced surveillance protocols and novel therapeutic approaches are needed to improve outcomes for patients with this rare ovarian cancer.